Delivery Order SPE2DB20D2104-SPE2DB25FMNQW
Award Date
4/16/25
Potential Completion Date
4/17/25
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,324.20 fixed-price delivery order is for the supply of the medication MYDAYIS ER 12.5 MG CAPSULE 100S, with a period of performance through March 2025. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This...
This federal contract award, valued at $1,598.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an ultimate completion date of October 30, 2024. The contract covers the supply of MYDAYIS ER 50 MG CAPSULE 100S, a pharmaceutical product, to support military healthcare programs. Amerisourcebergen holds a significant...
This is a $6,156.29 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of MYDAYIS ER 50 MG CAPSULE 100S, a pharmaceutical product, with a completion date of September 20, 2024. The contract is not set aside for any specific business type. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,037.41, is a delivery order (SPE2DX15D3017|SPE2DX24F0JKT) with the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The contract is for the supply of MYDAYIS ER 50 MG CAPSULE 100S, a pharmaceutical product. This contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award, with a ceiling value of $2,040.01, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of the pharmaceutical product MYDAYIS CAPS 25MG and is a firm fixed-price delivery order with an ultimate completion date of May 14, 2025. The contract is not set aside for any particular business type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
This federal contract award is for the delivery of pharmaceutical products, specifically MYDAYIS ER 37.5 MG CAPSULE 100S, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $2,971.74 and is a Firm Fixed Price Delivery Order. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not set aside and is an open competition award. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,226.81, is for the supply of 4568059545 MYDAYIS ER 12.5 MG CAPSULE 100S, a prescription medication. The contract is a Firm Fixed Price, non-set-aside award with an ultimate completion date of April 29, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor. The $1,107.02 firm fixed price delivery order is for the supply of MYDAYIS ER 50 MG CAPSULE 100S, a prescription medication. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a comprehensive...
This federal contract award, with ID SPE2DX15D3017|SPE2DX24F0NMT, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,363.43 firm fixed price delivery order is for the supply of MYDAYIS ER 50 MG CAPSULE 100S, a prescription medication. The contract has an ultimate completion date of September 17, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,801.24, is for the supply of MYDAYIS ER 25 MG CAPSULE 100S, a prescription medication. The contract has an ultimate completion date of March 19, 2025. AmerisourceBergen is a for-profit organization that has been registered in the System for Award Management (SAM.gov)...